Learn more about a new study that suggests early cancer detection could be as simple as a routine blood test.

New research suggests that an antibody-drug conjugate may offer practice-changing, patient-friendly treatment of blastic ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

Cell-free DNA-based liquid biopsies showed promise for monitoring response to pancreatic cancer therapies and making ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

New blood tests can detect cancer recurrence earlier than traditional scans, potentially giving doctors and patients crucial ...

At 38, author Jonathan Gluck was diagnosed with blood cancer and given less than three years to live. Twenty-two years later, ...

Revolutionary blood testing technology now identifies cancer and Alzheimer's disease before symptoms appear. Advanced genetic ...

A woman who was diagnosed with Hodgkin lymphoma, an uncommon type of blood cancer, has shared the symptoms she had in the ...

Hodgkin's lymphoma is an uncommon type of blood cancer. A woman who was diagnosed age 27 has shared some of the symptoms she ...

By Julie Steenhuysen CHICAGO (Reuters) -Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at ...

In new results, Proteomics International’s PromarkerEso blood test detected early oesophageal cancer with 91% accuracy, ...